Langerhans cells require signals from both tumour necrosis factor‐α and interleukin‐1β for migration
Open Access
- 1 November 1997
- journal article
- Published by Wiley in Immunology
- Vol. 92 (3) , 388-395
- https://doi.org/10.1046/j.1365-2567.1997.00360.x
Abstract
The induction phase of contact sensitization is associated with the movement of epidermal Langerhans cells (LC) from the skin and their migration, via afferent lymphatics, to draining lymph nodes where they accumulate as immunostimulatory dendritic cells (DC). It has been demonstrated previously that tumour necrosis factor‐α (TNF‐α) provides an important signal for LC migration and that in the absence of this cytokine, movement of LC from the epidermis to regional lymph nodes is inhibited. Recent evidence indicates that interleukin‐1β (IL‐1β), a cytokine produced in murine epidermis exclusively by LC, may also play a role in LC migration. The purpose of the investigations described here was to clarify, using relevant neutralizing anti‐cytokine antibodies, the contributions made by TNF‐α and IL‐1β to the migration of LC from the epidermis. It was found that like anti‐TNF‐α, anti‐IL‐1β administered systemically to mice (by intraperitoneal injection), prior to skin sensitization with the contact allergen oxazolone, resulted in a marked inhibition of DC accumulation in draining lymph nodes. It was shown also that anti‐IL‐1β inhibited TNF‐α‐induced LC migration and DC accumulation and that, in similar fashion, the stimulation of LC migration and DC accumulation induced by IL‐1β was compromised by prior treatment with anti‐TNF‐α. Based upon these data it is proposed that the stimulation of LC migration in response to skin sensitization requires the receipt by LC of two independent signals, one provided by TNF‐α and the other by IL‐1β. Morphological analyses of LC in epidermal sheets prepared from animals exposed to these cytokines with or without prior systemic treatment with anti‐cytokine antibody suggested that the changes induced in LC by TNF‐α and IL‐1β may include the altered expression of adhesion molecules and acquisition of the ability to interact with and pass through the basement membrane.Keywords
This publication has 33 references indexed in Scilit:
- Langerhans’ cells produce type IV collagenase (MMP‐9) following epicutaneous stimulation with haptensImmunology, 1997
- Mice deficient in IL-1beta manifest impaired contact hypersensitivity to trinitrochlorobenzone.The Journal of Experimental Medicine, 1996
- Flow cytometric analysis of cytokine receptors on human Langerhans' cells. Changes observed after short‐term cultureImmunology, 1996
- Human Langerhans Cells Express E-CadherinJournal of Investigative Dermatology, 1995
- Expression of E‐cadherin by murine dendritic cells: E‐cadherin as a dendritic cell differentiation antigen characteristic of epidermal Langerhans cells and related cellsEuropean Journal of Immunology, 1994
- Understanding the dendritic cell lineage through a study of cytokine receptors.The Journal of Experimental Medicine, 1994
- Langerhans Cells Are the Major Source of mRNA for IL-1β and MIP-1α Among Unstimulated Mouse Epidermal CellsJournal of Investigative Dermatology, 1992
- Cytokine gene expression in murine epidermal cell suspensions: interleukin 1 beta and macrophage inflammatory protein 1 alpha are selectively expressed in Langerhans cells but are differentially regulated in culture.The Journal of Experimental Medicine, 1992
- Intercellular adhesion molecule-1 (ICAM-1) expression by lymph node dendritic cells: comparison with epidermal Langerhans cellsImmunology Letters, 1992
- Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies.The Journal of Experimental Medicine, 1987